Risk Factors Update Summary
- Evaluation of strategic alternatives may result in substantial dilution to existing stockholders.
- System revenues derived from subscription-based model decreased from 42% to 33%.
- Accumulated deficit increased from $224,105 to $261,903 as of December 31, 2022 and 2023.
- Manufacturing operations in Israel may be disrupted due to military service obligations.
- Failure to maintain Nasdaq listing could lead to decreased liquidity and limited market quotations.
- Patent portfolio increased from 14 issued U.S. patents to 16 as of December 31, 2023.
- Market price volatility may impact the ability to resell shares of common stock.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1409269&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.